Mastic
is usually used to seal gaps in door frames, because it is a tough sticky gum. But, according to microbiologist Dlawer
Ala'Aldeen of Nottingham University, the gum from the leaves of the Middle Eastern
mastic tree -
Pistacia lentiscus - can also kill the bugs that cause ulcers. It
might one day lead to a new treatment for millions of sufferers without the expense and
problems associated with conventional drugs.
Ulcers are like open sores in the wall lining the stomach into which
acid can eat. Peptic ulcers can be very painful and are a major risk factor for stomach
cancer. Several years ago, Australian scientists demonstrated that a corkscrew-shaped
bacteria known as
Helicobacter pylori
(subject of the 2005 Nobel Prize for Medicine) was the most important cause so antibiotics.
Their findings overturned years of received wisdom regarding the nature of ulcers and for
many cases meant that using antacids and acid suppressants, such as ranitidine and cimetidine, was not likely to cure an ulcer but merely suppress the symptoms. The obvious
cure would be to use an antibiotic to kill the bug and so cut to the root of the ulcer.
The trouble with antibiotics is that bacteria develop resistance to them
quite quickly if they are not used properly and sometimes even if they are. So, while many
sufferers have been cured with a complex course of strong antibiotics, an alternative is
needed.
This is where the mastic gum comes in. Ala'Aldeen's co-worker Debbie
Thriwell, physician colleague Farhad Huwez and H pylori expert Alan Cockayne tested
whether mastic might help ulcer patients. They found that d research assistant found that
just 0.06 mg (0.00006 of a g/ml) was a high enough dose to kill the bacterium. Mastic,
says Ala'Aldeen, killed H pylori far more effectively than any antibiotic and
destroys even strains resistant to common antibiotics. The team is currently looking for
the active components of the gum to try to work out why it is so potent.
Mastic, it turns out, has been used as a traditional herbal remedy in
Kurdistan for centuries to treat stomach complaints - especially those caused by the
strong alcoholic drink arac, which is similar to Greek ouzo. Mastic, which tastes of
eucalyptus is also used a lot in traditional baking and soups, says
Ala'Aldeen. It seems
that folklore could assist modern medicine once again.
Ala'Aldeen et al., New Engl. J. Med.,
vol 339, p 1947.
Blocked up brains
AMERICAN SCIENTISTS HAVE
DISCOVERED that the brain is a lot cleverer than we thought at keeping out unwanted and
potentially harmful chemicals. They have found that in addition to the well-known
blood-brain barrier (the BBB) which blocks the path of many molecules into the brain,
there is a second layer of protection that catches compounds that try to smuggle their way
in. The discovery could have important implications for the development of therapies for
many different brain diseases.
Leslie Muldoon and Edward
Neuwelt of the Oregon Health Sciences University and the Portland Veterans Affairs
Medical Center in Portland know how to manipulate the blood-brain barrier so that they can
deliver drugs into the brains of patients with brain tumours without having to use
injections. They have spent several years developing techniques to lift this barrier by
using osmosis to make the tight junctions between blood vessel cells - which form the
barrier - open up and so allow patients to be treated without surgery.
However, they also know that some medical agents simply cannot get
through this border control. It would be useful if they could because it would mean
potential drugs and gene therapy agents for diseases such as Parkinson's and Alzheimer's
disease could be packaged up and delivered through the blood too.
Muldoon and her colleagues were looking into whether virus-sized
particles might be able to get into the brain. Gene therapy carrier, vectors, would be
this size so it is important to know whether it is possible or not. They were using
different types of 'sugar'-coated iron oxide particles to model a gene vector.
They found that the magnetic resonance images (MRI) they took showed a
strange distribution of some of the particles. It seemed as if some could get right into
the brain but others could not. This implied that there was a second barrier that was
holding back some types of particle. It turned out that the particles completely coated
with 'sugar' molecules could cross this second barrier but the incompletely covered
particles get stuck in the protein layer surrounding capillaries, likes flies in a
spider's web. Neuwelt believes the barrier is probably an electrically charged layer
similar to that found in the kidney. It can select which particles pass through depending
on their overall charge.
The next step for the scientists is to work out how to disguise useful
particles such as gene vectors so that they can get past the first and second barriers.
Muldoon et al., Am. J. Neuroradiol., 20, 217
Attacking arthritis
AN X-RAY
SNAPSHOT OF the enzymes involved in arthritis could lead to new drugs to treat the
disorder, according to American scientists.
Zinc-dependent matrix metalloproteinase (MMP) enzymes digest the
connective tissues surrounding cells. This process helps keep the spaces between cells
neat and tidy and allows cells to multiply. When things go wrong, however, the MMPs eat
away at tissues surrounding joints causing inflammation and destroying the joints leading
to the often-crippling pain of osteo- and rheumatoid-arthritis.
Only a few of the fifteen known MMPs are involved in arthritis so
finding a drug that blocks the damaging ones without interfering with the others is
difficult. If the wrong MMP is blocked waste proteins can build up between cells causing
their own problems.
Michelle Browner of Roche Bioscience in Palo Alto, California and her
co-workers have recorded the X-ray crystal structures of two MMPs in which they had loaded
inhibitor molecules - diphenylether sulfones - that stop them working. The X-ray
structures, which reveal the positions of every atom in the molecule, can be used to
produce an accurate computer model of the enzymes.
According to Browner the models demonstrate that how well a molecule
blocks the activity of the MMPs - human collagenase-1 and collagenase-3 - depends on the
size and shape of the 'pocket' in which the molecules fit. This pocket is long and open in
collagenase-3 so diphenylether sulfones, can fit. But, collagenase-1 has a smaller pocket
and the bulky diphenylether group of the compound simply cannot squeeze inside properly.
The researchers have developed inhibitor molecules that block different MMPs to different
degrees, based on their results.
Such molecules would hopefully avoid potential side effects and
might one day lead to new drugs for arthritis.
Browner et al., Nature Struct. Biol., 1999,
217
Read more
scientific discoveries news,
medical
news headlines, and
chemistry articles
Back to the sciencebase
homepage